Saturday, July 11, 2026

Drug profile · INN

rhgm-csf

rhgm-csf is a granulocyte colony stimulating factor receptor agonist.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — rhgm-csf
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

rhgm-csf is a granulocyte colony stimulating factor receptor agonist.

Key facts

INN rhgm-csf
Mechanism Granulocyte colony stimulating factor receptor agonist
Target Granulocyte colony-stimulating factor receptor

Mechanism of action

Granulocyte colony stimulating factor receptor agonist

Primary target: Granulocyte colony-stimulating factor receptor

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. rhGM-CSF Phase 2 · Chinese Academy of · Pulmonary Alveolar Proteinosis
  2. rhGM-CSF group Approved · BioMarin Pharmaceutical · Mycoses
  3. rhGM-CSF group Approved · First People's Hospital · Mycoses

Related & competitor drugs

  1. filgrastim Antineoplastic and immunomodulating agents (L03)
  2. lipegfilgrastim Antineoplastic and immunomodulating agents (L03)
  3. pegfilgrastim-cbqv Granulocyte colony stimulating factor receptor agonist
  4. efbemalenograstim alfa-vuxw Granulocyte colony stimulating factor receptor agonist
  5. eflapegrastim-xnst Granulocyte colony stimulating factor receptor agonist
  6. filgrastim-aafi Granulocyte colony stimulating factor receptor agonist

Frequently asked questions

What is rhgm-csf?

rhgm-csf is a granulocyte colony stimulating factor receptor agonist.